XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Net Loss Per Share

9.

Net Loss Per Share

Basic and diluted net loss per share was calculated as follows for the three and six months ended June 30, 2021 and 2020:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Basic net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss (in thousands)

 

$

(107,245

)

 

$

(136,347

)

 

$

(203,009

)

 

$

(263,087

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding

   —basic

 

 

58,582,569

 

 

 

51,926,074

 

 

 

58,478,970

 

 

 

51,917,417

 

Dilutive effect of shares of common stock

   equivalents resulting from common stock

   options and restricted stock units

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding

   —diluted

 

 

58,582,569

 

 

 

51,926,074

 

 

 

58,478,970

 

 

 

51,917,417

 

Net loss per share—basic and diluted

 

$

(1.83

)

 

$

(2.63

)

 

$

(3.47

)

 

$

(5.07

)

 

 

The following common stock equivalents outstanding as of June 30, 2021 and 2020 were excluded from the calculation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Stock options

 

 

7,048,814

 

 

 

7,172,273

 

 

 

7,048,814

 

 

 

7,172,273

 

Restricted stock units

 

 

333,220

 

 

 

523,870

 

 

 

333,220

 

 

 

523,870

 

Employee stock purchase plan

 

 

28,687

 

 

 

39,290

 

 

 

28,687

 

 

 

39,290

 

 

 

 

7,410,721

 

 

 

7,735,433

 

 

 

7,410,721

 

 

 

7,735,433

 

 

Stock options and restricted stock units that are outstanding and contain performance-based vesting criteria for which the performance conditions have not been met are excluded from the calculation of common stock equivalents outstanding.